Metabolites
Displaying metabolites 2201 - 2225 of 3755 in total
Metabolite ID | Name CAS Number | IUPAC Name | SMPDB Pathways | Weight Formula | Structure |
---|---|---|---|---|---|
ECMDB11629 | Guanosine 2',3'-cyclic phosphate 15718-49-7 | 9-[(3aR,4R,6R,6aR)-2-hydroxy-6-(hydroxymethyl)-2-oxo-tetrahydro-2H-2λ⁵-furo[3,4-d][1,3,2]dioxaphosphol-4-yl]-2-amino-6,9-dihydro-3H-purin-6-one | 345.2053 C10H12N5O7P | ||
ECMDB20158 | Guanosine 3',5'-bis(diphosphate) 33503-72-9 | {[hydroxy({[(2R,3S,4R,5R)-4-hydroxy-2-({[hydroxy(phosphonooxy)phosphoryl]oxy}methyl)-5-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)oxolan-3-yl]oxy})phosphoryl]oxy}phosphonic acid | 603.1603 C10H17N5O17P4 | ||
ECMDB20156 | Guanosine 3'-diphosphate 5'-triphosphate 38918-96-6 | {[hydroxy({[(2R,3S,4R,5R)-4-hydroxy-2-({[hydroxy({[hydroxy(phosphonooxy)phosphoryl]oxy})phosphoryl]oxy}methyl)-5-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)oxolan-3-yl]oxy})phosphoryl]oxy}phosphonic acid | 683.1402 C10H18N5O20P5 | ||
ECMDB20157 | Guanosine 3'-phosphate 117-68-0 | {[4-hydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)-2-(hydroxymethyl)oxolan-3-yl]oxy}phosphonic acid | 363.2206 C10H14N5O8P | ||
ECMDB01201 | Guanosine diphosphate 146-91-8 | [({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]phosphonic acid | 443.2005 C10H15N5O11P2 | ||
ECMDB01163 | Guanosine diphosphate mannose 3123-67-9 | [({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy]({[(2R,3S,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy})phosphinic acid | 605.3411 C16H25N5O16P2 | ||
ECMDB01397 | Guanosine monophosphate 85-32-5 | {[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid | 363.2206 C10H14N5O8P | ||
ECMDB01273 | Guanosine triphosphate 86-01-1 | ({[({[(2R,3S,4R,5R)-5-(2-amino-6-oxo-6,9-dihydro-1H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid | Pyrimidine metabolism PW000942 Folate biosynthesis PW000908 Amino sugar and nucleotide sugar metabolism II PW000887 Aspartate metabolism PW000787 More...GTP degradation PW001888 Mannose Metabolism PW000822 adenosylcobalamin salvage from cobinamide PW001884 colanic acid building blocks biosynthesis PW000951 preQ0 metabolism PW001893 purine nucleotides de novo biosynthesis PW000910 purine nucleotides de novo biosynthesis 1435709748 PW000960 Flavin biosynthesis PW001971 guanylyl molybdenum cofactor biosynthesis PW002032 purine nucleotides de novo biosynthesis 2 PW002033 Tetrahydromonapterin Biosynthesis PW002043 | 523.1804 C10H16N5O14P3 | |
ECMDB23729 | Guanosine-3'-diphosphate 5'-phosphate | {[hydroxy({[(2R,3S,4R,5R)-4-hydroxy-5-(6-hydroxy-2-imino-3,9-dihydro-2H-purin-9-yl)-2-[(phosphonooxy)methyl]oxolan-3-yl]oxy})phosphoryl]oxy}phosphonic acid | 523.1804 C10H16N5O14P3 | ||
ECMDB23737 | Halide | (3E)-3-{2-[(2-{3-[(2R)-3-[({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-4-hydroxy-3-(phosphonooxy)oxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)methyl]-2-hydroxy-3-methylbutanamido]propanamido}ethyl)sulfanyl]-2-oxoethylidene}-7-methyloct-6-enoic acid | Glutathione metabolism PW000833 | 961.76 C32H50N7O19P3S | |
ECMDB24176 | HClO | hypochlorous acid | 52.46 ClHO | ||
ECMDB03178 | Heme 14875-96-8 | 4,20-bis(2-carboxyethyl)-10,15-diethenyl-5,9,14,19-tetramethyl-2lambda5,22,23lambda5,25-tetraaza-1-ferraoctacyclo[11.9.1.1^{1,8}.1^{3,21}.0^{2,6}.0^{16,23}.0^{18,22}.0^{11,25}]pentacosa-2,4,6,8,10,12,14,16(23),17,19,21(24)-undecaene-2,23-bis(ylium)-1,1-diuide | 616.487 C34H32FeN4O4 | ||
ECMDB20564 | Heme D 60318-31-2 | 3-[20-(2-carboxyethyl)-10,15-bis(carboxymethyl)-5,10,15,19-tetramethyl-9,14-dioxo-21,22,23,24-tetraazapentacyclo[16.2.1.1³,⁶.1⁸,¹¹.1¹³,¹⁶]tetracosa-1(20),2,4,6,8(23),11,13(22),16,18-nonaen-4-yl]propanoic acid | 658.6546 C34H34N4O10 | ||
ECMDB01162 | Heme O 137397-56-9 | 3-[(11Z,16Z)-20-(2-carboxyethyl)-15-ethenyl-10-[(4E,8E)-1-hydroxy-5,9,13-trimethyltetradeca-4,8,12-trien-1-yl]-5,9,14,19-tetramethyl-21,23,24,25-tetraaza-22-ferrahexacyclo[9.9.3.1³,⁶.1¹³,¹⁶.0⁸,²³.0¹⁸,²¹]pentacosa-1(20),2,4,6(25),7,9,11,13(24),14,16,18-undecaen-4-yl]propanoic acid | 838.854 C49H58FeN4O5 | ||
ECMDB21538 | Heptadecenoic acid 26265-99-6 | (2E)-heptadec-2-enoic acid | 268.4348 C17H32O2 | ||
ECMDB20526 | Heptosyl-KDO2-lipid A | (2R,4R,5R,6R)-4-{[6-(1,2-dihydroxyethyl)-2-(dihydroxymethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-[(1R)-1,2-dihydroxyethyl]-5-{[(3S,4S,5S)-6-[(1S)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-2-{[(2R,3S,4R,5R,6R)-6-{[(2R,3S,4R,5R,6R)-5-{[(3R)-1,3-dihydroxytetradecylidene]amino}-3-hydroxy-4-{[(3R)-3-hydroxytetradecanoyl]oxy}-6-(phosphonooxy)oxan-2-yl]methoxy}-5-{[(3R)-3-(dodecanoyloxy)-1-hydroxytetradecylidene]amino}-3-(phosphonooxy)-4-{[(3R)-3-(tetradecanoyloxy)tetradecanoyl]oxy}oxan-2-yl]methoxy}oxane-2-carboxylic acid | 2424.871 C117H208N2O45P2 | ||
ECMDB21342 | Heptosyl-phospho-heptosyl-heptosyl-kdo2-lipidA | (2R,4R,5R,6R)-4-{[2-carboxylato-6-(1,2-dihydroxyethyl)-4,5-dihydroxyoxan-2-yl]oxy}-5-{[(3S,4S,5R)-4-{[(3S,4R,5S)-6-[(1S)-2-{[6-(1,2-dihydroxyethyl)-3,4,5-trihydroxyoxan-2-yl]oxy}-1-hydroxyethyl]-3,4-dihydroxy-5-(phosphonatooxy)oxan-2-yl]oxy}-6-[(1S)-1,2-dihydroxyethyl]-3,5-dihydroxyoxan-2-yl]oxy}-6-[(1R)-1,2-dihydroxyethyl]-2-{[(2R,3S,4R,5R,6R)-5-{[(3R)-3-(dodecanoyloxy)-1-oxidotetradecylidene]amino}-6-{[(2R,3S,4R,5R,6R)-3-hydroxy-5-{[(3R)-3-hydroxy-1-oxidotetradecylidene]amino}-4-{[(3R)-3-hydroxytetradecanoyl]oxy}-6-(phosphonooxy)oxan-2-yl]methoxy}-3-(phosphonatooxy)-4-{[(3R)-3-(tetradecanoyloxy)tetradecanoyl]oxy}oxan-2-yl]methoxy}oxane-2-carboxylate | 2887.1345 C131H231N2O60P3 | ||
ECMDB20527 | Heptosyl2-KDO2-lipid A | (2R,4R,5R,6R)-4-{[6-(1,2-dihydroxyethyl)-2-(dihydroxymethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-[(1R)-1,2-dihydroxyethyl]-5-{[(3S,4S,5R)-6-[(1S)-1,2-dihydroxyethyl]-4-{[(3S,4S,5S)-6-[(1S)-1,2-dihydroxyethyl]-3,4,5-trihydroxyoxan-2-yl]oxy}-3,5-dihydroxyoxan-2-yl]oxy}-2-{[(2R,3S,4R,5R,6R)-6-{[(2R,3S,4R,5R,6R)-5-{[(3R)-1,3-dihydroxytetradecylidene]amino}-3-hydroxy-4-{[(3R)-3-hydroxytetradecanoyl]oxy}-6-(phosphonooxy)oxan-2-yl]methoxy}-5-{[(3R)-3-(dodecanoyloxy)-1-hydroxytetradecylidene]amino}-3-(phosphonooxy)-4-{[(3R)-3-(tetradecanoyloxy)tetradecanoyl]oxy}oxan-2-yl]methoxy}oxane-2-carboxylic acid | Lipopolysaccharide biosynthesis PW000831 | 2625.0674 C124H228N2O51P2 | |
ECMDB21226 | Hexadecanoyl-phosphate (n-C16:0) | (hexadecanoyloxy)phosphonate | 334.3881 C16H31O5P | ||
ECMDB21229 | Hexanoate (N-C6:0) | hexanoic acid | 115.1503 C6H11O2 | ||
ECMDB02845 | Hexanoyl-CoA 5060-32-2 | {[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-2-({[({[(3R)-3-[(2-{[2-(hexanoylsulfanyl)ethyl]carbamoyl}ethyl)carbamoyl]-3-hydroxy-2,2-dimethylpropoxy](hydroxy)phosphoryl}oxy)(hydroxy)phosphoryl]oxy}methyl)-4-hydroxyoxolan-3-yl]oxy}phosphonic acid | Fatty acid metabolism PW000796 | 865.677 C27H46N7O17P3S | |
ECMDB03287 | Histidinol phosphate 25680-11-9 | [(2S)-2-amino-3-(1H-imidazol-4-yl)propoxy]phosphonic acid | Phenylalanine metabolism PW000921 | 221.1509 C6H12N3O4P | |
ECMDB00745 | Homocarnosine 3650-73-5 | (2S)-2-(4-aminobutanamido)-3-(1H-imidazol-4-yl)propanoic acid | inner membrane transport PW000786 | 240.259 C10H16N4O3 | |
ECMDB24053 | Homocysteine | 2-amino-4-sulfanylbutanoic acid | 135.185 C4H9NO2S | ||
ECMDB20567 | Homoserine lactone 1192-20-7 | 3-aminooxolan-2-one hydrobromide | 182.016 C4H8BrNO2 |